CalciMedica flags Nasdaq noncompliance as market value falls below USD 35 million

Reuters03-19
CalciMedica flags Nasdaq noncompliance as market value falls below USD 35 million

CalciMedica received a Nasdaq notice that it is not in compliance with Listing Rule 5550(b)(2) after its market value of listed securities stayed below USD 35 million for 30 consecutive business days. The company has until September 9, 2026 to regain compliance, including by maintaining a market value of listed securities of at least USD 35 million for at least 10 consecutive business days. CalciMedica also received a Nasdaq notice that it is not in compliance with Listing Rule 5550(a)(2) because its minimum bid price was below USD 1 per share for 30 consecutive business days. The company has until September 14, 2026 to regain compliance by maintaining a minimum bid price of at least USD 1 per share for at least 10 consecutive business days.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-114096), on March 18, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment